Moderna
MRNA
MRNA
889 hedge funds and large institutions have $28.1B invested in Moderna in 2024 Q1 according to their latest regulatory filings, with 108 funds opening new positions, 328 increasing their positions, 292 reducing their positions, and 80 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
889
Holders Change
+16
Holders Change %
+1.83%
% of All Funds
12.89%
Holding in Top 10
8
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-27.27%
% of All Funds
0.12%
New
108
Increased
328
Reduced
292
Closed
80
Calls
$1.61B
Puts
$1.32B
Net Calls
+$288M
Net Calls Change
-$179M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$768M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$547M |
| 3 |
Pictet Asset Management
Carouge,
Switzerland
|
+$88.5M |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$83.1M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$73.3M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$350M |
| 2 |
Coatue Management
New York
|
-$326M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$173M |
| 4 |
JPMorgan Chase & Co
New York
|
-$116M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$106M |
